Разрешен к применению с 1995 года.
Видео о
Купить в
COVID-19 
По алфавиту
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- V
- W
- X
- Y
- Z
- І
- А
- Б
- В
- Г
- Д
- Е
- Ж
- З
- И
- К
- Л
- М
- Н
- О
- П
- Р
- С
- Т
- У
- Ф
- Х
- Ц
- Ч
- Ш
- Щ
- Э
- Ю
- Я
- Весь список
Warning: mb_strpos(): Empty delimiter in /var/www/u1363561/data/www/biotech.spb.ru/wp-content/plugins/code-snippets/php/snippet-ops.php(581) : eval()’d code(4) : eval()’d code on line 13
H Kirchner, A Körfer, P A Palmer, P Evers, W De Riese, J Knüver-Hopf, M Hadam, U Goldman, C R Franks, H Poliwoda, et al.
Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experienceMol Biother. 1990 Sep;2(3):145-54.
Ha Kim, Byungsuk Kwon, Jeong-Im Sin
Combined stimulation of IL-2 and 4-1BB receptors augments the antitumor activity of E7 DNA vaccines by increasing Ag-specific CTL responsesPLoS One. 2013 Dec 31;8(12):e83765.
Hanson K.P., Moiseyenko V.M., Orlova R.V. et al.
Efficacy of the chemoimmunotherapy in previously treated patients with malignant metastatic skin melanoma.
10th International congress on anti-cancer treatmentю Paris-France, 2000. P. 117.
Harel-Bellan A, Bertoglio J, Quillet A et al.
Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.J Immunol. 1986 Apr 1;136(7):2463-9. PMID: 3005412.
Hideaki Miyake, Isao Hara, Iori Sakai, Ken-ichi Harada, Taka-aki Inoue, Hiroshi Eto, Yoshizumi Takechi, Masato Fujisawa
Clinical outcome of combined immunotherapy with low-dose interleukin-2 and interferon-alpha for Japanese patients with metastatic renal cell carcinoma who had undergone radical nephrectomy: a preliminary reportInt J Clin Oncol. 2005 Oct;10(5):338-41.
Hongbo Shi, Wenjing Wang, Jiming Yin tn al. 
PDF 
ZIP
Cell Death and Disease (2020) 11:429
Hosten B, Abbara C, Cibert M et al.
Interleukin-2 treatment effect on imatinib pharmacokinetic, P-gp and BCRP expression in mice.Anticancer Drugs. 2010 Feb;21(2):193-201.
Hosten B., Abbara C., Petit B. et al.
Effect of interleukin-2 pretreatment on paclitaxel absorption and tissue disposition after oral and intravenous administration in mice.Drug Metab Dispos. 2008 Aug;36(8):1729-35. doi: 10.1124/dmd.107.019091. Epub 2008 May 28.
Hotchkiss R.S., Colston E., Yende S. et al. PDF
Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 (BMS-936559).
Critical Care Medicine. — 2019. — V. XX. — N. XXX. — P. 1-11.
В соответствии с п. 1 ст. 64 Федерального закона от 12.04.2010 № 61-ФЗ "Об обращении лекарственных средств" лекарственные препараты, находящиеся в обращении на территории Российской Федерации, подлежат мониторингу безопасности в целях выявления возможных негативных последствий их применения, предупреждения пациентов и их защиты от применения таких препаратов.